We were haunted by the same dilemma, namely that whereas there was not much we could offer our cancer patients, there were so many potential technologies we encountered in the lab which could address this.
Nos obsesionaba el mismo dilema, que aunque no pudiéramos ofrecer mucho a nuestros pacientes con cáncer, encontramos que en el laboratorio había muchas tecnologías potenciales que podrían resolver esto.